glp 1 and gip dual agonist The action of tirzepatide on various organs. GLP-1: Review Article: GLP‐1 Receptor Agonists
Description
2 Literature search strategy This narrative review aimed to synthesize current mechanistic and clinical evidence regarding tirzepatide in obesity-related OSAS
Acute kidney injury: diarrhea, nausea, and vomiting may lead to dehydration which may cause kidney problems such as acute kidney injury and, in rare cases, requiring hemodialysis
Other GLP-1s like Wegovy and Zepbound are specifically indicated to treat obesity and overweight with related health conditions
Considering the growing burden of obesity and diabetes, there has been a rise in the need for safe and effective medications
Diabetes 68 , 683695 (2019)
